Calavo Growers (NASDAQ:CVGW) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.33 by 90.91 percent. This is a 137.5 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $243.57 million which missed the analyst consensus estimate of $297.97 million by 18.26 percent. This is a 10.92 percent decrease over sales of $273.42 million the same period last year.
PharmaCyte Biotech Provides Corporate Update On Cell-In-A-Box Technology
Company prepares for comprehensive discussion with FDA to determine appropriate next steps for technology while evaluating additional opportunitiesPharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company")
